CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

93 hedge funds and large institutions have $264M invested in Concert Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+3
Holders Change %
+3.33%
% of All Funds
2.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
19
Increased
32
Reduced
29
Closed
16
Calls
$37K
Puts
$113K
Net Calls
-$76K
Net Calls Change
+$940K

Top Buyers

1
NI
1
Numeric Investors
Massachusetts
$10.1M
2
OAM
2
Oxford Asset Management
United Kingdom
$5.99M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$3.58M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$4.26M
5
Prudential Financial
5
Prudential Financial
New Jersey
$4.12M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$0
2
TC
2
TFS Capital
Pennsylvania
$1.98M
3
SAM
3
Senzar Asset Management
New York
$27.2M
4
Morgan Stanley
4
Morgan Stanley
New York
$3.39M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AL
101
Airain Ltd
Guernsey
– -$415K -22,126 Closed
SCA
102
Secor Capital Advisors
New York
– -$334K -17,804 Closed
SKK
103
Shepherd Kaplan Krochuk
Massachusetts
– -$282K -15,002 Closed
GAM
104
Gotham Asset Management
New York
– -$232K -12,367 Closed
Goldman Sachs
105
Goldman Sachs
New York
– -$219K -11,679 Closed
DTL
106
Dynamic Technology Lab
Singapore
– -$212K -11,312 Closed
PA
107
Perceptive Advisors
New York
– -$195K -10,379 Closed
PAM
108
Panagora Asset Management
Massachusetts
– -$58K -3,088 Closed
BlackRock
109
BlackRock
New York
– -$8K -400 Closed
1 2 3 4
5